banner
Pwodwi kategori
Kontakte nou

Kontakte:Errol Zhou (Mesye.)

Tel: plis 86-551-65523315

Mobile/WhatsApp: plis 86 17705606359

QQ:196299583

Skype:lucytoday@hotmail.com

Imèl:sales@homesunshinepharma.com

Ajoute:1002, Huanmao Bilding, No.105, Mengcheng Wout, Hefei Vil, 230061, Lachin

API ak Entèmedyè
Pirtobrutinib CAS 2101700-15-4

Pirtobrutinib CAS 2101700-15-4

Nimewo CAS:2101700-15-4
Fòmil molekilè: C22H21F4N5O3
Pwa molekilè: 479,43
EINECS NON:864-730-9
MDL nimewo: MFCD34179491

Pwodwi detay

Deskripsyon Product:

Non pwodwi: Pirtobrutinib CAS 2101700-15-4

 

Sinonim:

(S)-5-amino-3-(4-((5-fluoro-2-metoksibenzamido)metil)fenil)-1-(1,1,{ {8}}trifluoropropan-2-il)-1H-pirazol-4-karboksamid;

LOXO-305;

LY 3527727.

 

Pwopriyete Chimik ak Fizik

Aparans: poud solid blan blan blan

Esè: NLT99%

Pwen bouyi: 619.2 degre

Dansite: 1.44 ± 0.1 g/cm3 (Prevwa)

Solibilite: DMSO: 50 mg/mL (104.29 mM; Bezwen ultrasons)

 

Aplikasyon: Pirtobrutinib, konnen tou kòm LOXO-305 ak LY 3527727, se yon inibitè tirozin kinaz (BTK) Bruton ak ajan antineoplastic. Pirtobrutinib te montre pwomès premye efikasite nan pts ak transfòmasyon Richter pretrete ak pronostik trè pòv, ki gen ladan nan pasyan ki te resevwa anvan chimyoimmunoterapi ak kovalan inibitè BTK. Pirtobrutinib se yon inibitè BTK ki pa kovalan (BTKi) trè selektif ak pisan ki gen gwo byodisponibilite oral ak yon mwatye lavi ki long, sa ki lakòz pwoteksyon sib BTK gaya menm nan maladi malfezan segondè ak woulman pwoteyin BTK segondè.

 

Pirtobrutinib, yon trè selektif ak ki pa kovalan pwochen jenerasyon inhibitor BTK, inibit divès mitasyon sibstitisyon BTK C481. Pirtobrutinib lakòz regression timè lenfom ki depann de BTK nan modèl xenograft sourit. Pirtobrutinib tou se plis pase 300-pliye selektif pou BTK kont 370 lòt kinaz yo teste epi li pa montre okenn anpèchman enpòtan nan sib ki pa kinaz nan 1 μM.

 

Nou kapab tou bay Pirtobrutinib entèmedyè:

4-[[(5-fluoro-2-methoxy-benzoyl)amino]methyl]benzoic asid CAS 1571888-11-3;

N-[[4-(2,2-dicyano-1-metoksi-vinil)fenil]methyl]-5-fluoro-2-metoksi-benzamid CAS {{9} };

[(1S)-2,2,2-tri-fluoro-1-methyl-ethyl]hydrazin CAS 2764851-02-5;

[(1S)-2,2,2-trifluoro-1-methylethyl]hydrazin hydrochloride CAS 2764851-03-6.

 

 

Si w enterese nan pwodwi nou yo oswa si w gen nenpòt kesyon, tanpri ou lib pou kontakte nou!

 

 

Pwodwi anba patant yo ofri pou rezon R & D sèlman. Sepandan, responsablite final la se sèlman nan achtè a.

Baj popilè: pirtobrutinib cas 2101700-15-4, manifaktirè, founisè, faktori, achte, nan stock

Voye rechèch